Corrigendum to “miR-183-5p Is a Potential Molecular Marker of Systemic Lupus Erythematosus”

Shaolan Zhou,Jing Zhang,Pengfei Luan,Zhanbing Ma,Jie Dang,Hong Zhu,Qian Ma,Yanfeng Wang,Zhenghao Huo

DOI: https://doi.org/10.1155/2021/9818203

IF: 4.4929

2021-09-04

Journal of Immunology Research

Abstract:[This corrects the article DOI: 10.1155/2021/5547635.].

immunology

What problem does this paper attempt to address?

Corrigendum: Alternative Splicing: a New Cause and Potential Therapeutic Target in Autoimmune Disease.

Pingping Ren,Luying Lu,Shasha Cai,Jianghua Chen,Weiqiang Lin,Fei Han

DOI: https://doi.org/10.3389/fimmu.2024.1513491

IF: 7.3

2024-01-01

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2021.713540.].
Corrigendum: MicroRNAs: Potential mediators between particulate matter 2.5 and Th17/Treg immune disorder in primary membranous nephropathy

Xiaoshan Zhou,Haoran Dai,Hanxue Jiang,Hongliang Rui,Wenbin Liu,Zhaocheng Dong,Na Zhang,Qihan Zhao,Zhendong Feng,Yuehong Hu,Fanyu Hou,Yang Zheng,Baoli Liu

DOI: https://doi.org/10.3389/fphar.2023.1166591

IF: 5.6

2023-02-27

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2022.968256.].

pharmacology & pharmacy
Corrigendum to “Lipopolysaccharide-Induced Podocyte Injury is Regulated by Calcineurin/nfat and TLR4/MyD88/NF-κB Signaling Pathways Through Angiopoietin-like Protein 4” [genes & Diseases 9(2022) 443–455]

Xiaohua Shen,Chunhua Weng,Yucheng Wang,Cuili Wang,Feng Shi,Xiayu Li,Heng Li,Hong Jiang,Haibing Wang,Jianghua Chen

DOI: https://doi.org/10.1016/j.gendis.2022.03.001

IF: 7.376

2022-01-01

Genes & Diseases

Abstract:[This corrects the article DOI: 10.1016/j.gendis.2020.07.005.][This corrects the article DOI: 10.1016/j.gendis.2021.09.001.].
Corrigendum: MicroRNAs as Regulators of Immune and Inflammatory Responses: Potential Therapeutic Targets in Diabetic Nephropathy

Hong Zhou,Wei-Jian Ni,Xiao-Ming Meng,Li-Qin Tang

DOI: https://doi.org/10.3389/fcell.2022.875280

IF: 5.5

2022-03-01

Frontiers in Cell and Developmental Biology

Abstract:[This corrects the article DOI: 10.3389/fcell.2020.618536.].

cell biology,developmental biology
Erratum: [Corrigendum] miR‑216a‑5p acts as an oncogene in renal cell carcinoma.

Peijie Chen,Jing Quan,Lu Jin,Canbin Lin,Weijie Xu,Jinling Xu,Xin Guan,Zebo Chen,Liangchao Ni,Shangqi Yang,Yun Chen,Yongqing Lai

DOI: https://doi.org/10.3892/etm.2024.12443

IF: 2.7

2024-01-01

Experimental and Therapeutic Medicine

Abstract:[This corrects the article DOI: 10.3892/etm.2018.5881.].
Corrigendum: The Regulation Mechanisms and Clinical Application of MicroRNAs in Myocardial Infarction: A Review of the Recent 5 Years

Chan Wu,Binghong Liu,Ruiying Wang,Gang Li

DOI: https://doi.org/10.3389/fcvm.2022.900621

2022-05-12

Abstract:[This corrects the article DOI: 10.3389/fcvm.2021.809580.].
Corrigendum: A Novel Autoantibody Induced by Bacterial Biofilm Conserved Components Aggravates Lupus Nephritis

Wenyan Fu,Yu Liu,Fangjie Liu,Chenghua Liu,Jingjing Li,Jiali Niu,Peng Han,Dan Xu,Jiaojiao Hou,Yuanfang Ma,Jiannan Feng,Zhanguo Li,Rong Mu,Guang Yang

DOI: https://doi.org/10.3389/fimmu.2021.819846

IF: 7.3

2021-12-17

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2021.656090.].

immunology
Corrigendum: The potential role of RNA N6-methyladenosine in primary Sjögren's syndrome

Qiufeng Xiao,Xunyao Wu,Chuiwen Deng,Lidan Zhao,Linyi Peng,Jiaxin Zhou,Wen Zhang,Yan Zhao,Yunyun Fei

DOI: https://doi.org/10.3389/fmed.2023.1251795

IF: 3.9

2023-07-11

Frontiers in Medicine

Abstract:[This corrects the article DOI: 10.3389/fmed.2022.959388.].

medicine, general & internal
Erratum to: "Fer exacerbates renal fibrosis and can be targeted by miR-29c-3p"

Chen-Min Sun,Wen-Yi Zhang,Shu-Yan Wang,Gang Qian,Dong-Liang Pei,Guang-Ming Zhang

DOI: https://doi.org/10.1515/med-2023-0755

2023-07-07

Abstract:[This corrects the article DOI: 10.1515/med-2021-0319.].
Corrigendum: Identification and validation of immune-related methylation clusters for predicting immune activity and prognosis in breast cancer

Anli Yang,Ying Zhou,Yanan Kong,Xiaoli Wei,Feng Ye,Lijuan Zhang,Xian Zhong,Mingyue Li,Shilin Lu,Xin An,Weikai Xiao

DOI: https://doi.org/10.3389/fimmu.2024.1372991

IF: 7.3

2024-01-31

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2021.704557.].

immunology
Corrigendum to"Synergistically targeting synovium STING pathway for rheumatoid arthritis treatment" [Bioact Mater 24 (2022) 37-53]

Haotian Shen,Lulu Jin,Qiangqiang Zheng,Ziqiang Ye,Linxiang Cheng,Yuxu Wu,Honghao Wu,Tae Gyong Jon,Wenduo Liu,Zongyou Pan,Zhengwei Mao,Yue Wang

DOI: https://doi.org/10.1016/j.bioactmat.2024.08.007

2024-08-22

Abstract:[This corrects the article DOI: 10.1016/j.bioactmat.2022.12.001.].
Corrigendum to “Lipopolysaccharide-induced podocyte injury is regulated by calcineurin/NFAT and TLR4/MyD88/NF-κB signaling pathways through Angiopoietin-like protein 4” [Genes & Diseases 9(2022) 443-455]

Xiujin Shen,Chunhua Weng,Yucheng Wang,Cuili Wang,Shi Feng,Xiayu Li,Heng Li,Hong Jiang,Haibing Wang,Jianghua Chen

DOI: https://doi.org/10.1016/j.gendis.2022.03.001

2022-03-01

Abstract:[This corrects the article DOI: 10.1016/j.gendis.2020.07.005.][This corrects the article DOI: 10.1016/j.gendis.2021.09.001.].

genetics & heredity,biochemistry & molecular biology
Erratum to “miR-223 Inhibits the Polarization and Recruitment of Macrophages via NLRP3/IL-1β Pathway to Meliorate Neuropathic Pain”

Junsong Zhu,Jinmei Yang,Jianguo Xu

DOI: https://doi.org/10.1155/2023/9756947

2023-03-09

Pain Research and Management

Abstract:[This corrects the article DOI: 10.1155/2021/6674028.].

clinical neurology
[Corrigendum] miR‐216a‐5p acts as an oncogene in renal cell carcinoma

Peijie Chen,Jing Quan,Lu Jin,Canbin Lin,Weijie Xu,Jinling Xu,Xin Guan,Zebo Chen,Liangchao Ni,Shangqi Yang,Yun Chen,Yongqing Lai

DOI: https://doi.org/10.3892/etm.2024.12443

IF: 2.7

2024-02-21

Experimental and Therapeutic Medicine

Abstract:[This corrects the article DOI: 10.3892/etm.2018.5881.].

medicine, research & experimental
Corrigendum: Metabolomic analysis in spondyloarthritis: A systematic review

Tianwen Huang,Yaoyu Pu,Xiangpeng Wang,Yanhong Li,Hang Yang,Yubin Luo,Yi Liu

DOI: https://doi.org/10.3389/fmicb.2022.1100290

IF: 5.2

2022-12-12

Frontiers in Microbiology

Abstract:[This corrects the article DOI: 10.3389/fmicb.2022.965709.].

microbiology
[Corrigendum] miR‐199b‐5p serves as a tumor suppressor in renal cell carcinoma

Yulin Lai,Jing Quan,Canbin Lin,Hang Li,Jia Hu,Peijie Chen,Jinling Xu,Xin Guan,Weijie Xu,Yongqing Lai,Liangchao Ni

DOI: https://doi.org/10.3892/etm.2024.12422

IF: 2.7

2024-02-09

Experimental and Therapeutic Medicine

Abstract:[This corrects the article DOI: 10.3892/etm.2018.6151.].

medicine, research & experimental
Corrigendum to "N6-methyladenosine modified LINC00901 promotes pancreatic cancer progression through IGF2BP2/MYC axis" [Genes & Diseases 10 (2023) 554-567]

Wan-Xin Peng,Fei Liu,Jia-Hong Jiang,Hang Yuan,Ziqiang Zhang,Liu Yang,Yin-Yuan Mo

DOI: https://doi.org/10.1016/j.gendis.2024.101352

2024-06-15

Abstract:[This corrects the article DOI: 10.1016/j.gendis.2022.02.014.].
Erratum to "Inhibition of miR-21 improves pulmonary vascular responses in bronchopulmonary dysplasia by targeting the DDAH1/ADMA/NO pathway"

Ying Zhong,Zhiqun Zhang,Xiaoqing Chen

DOI: https://doi.org/10.1515/med-2023-0679

2023-03-13

Abstract:[This corrects the article DOI: 10.1515/med-2022-0584.].
Corrigendum: Single-cell RNA Sequencing of Peripheral Blood Mononuclear Cells from Acute Myocardial Infarction.

Jun Qian,Yanhua Gao,Yan Lai,Zi Ye,Yian Yao,Keke Ding,Jing Tong,Hao Lin,Guoqi Zhu,Yunan Yu,Haoran Ding,Deqiang Yuan,Jiapeng Chu,Fei Chen,Xuebo Liu

DOI: https://doi.org/10.3389/fimmu.2024.1462970

IF: 7.3

2024-01-01

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2022.908815.].
Corrigendum: A novel LncRNA, AC091729.7 promotes sinonasal squamous cell carcinomas proliferation and invasion through binding SRSF2

Boyu Yu,Linmei Qu,Tianyi Wu,Bingrui Yan,Xuan Kan,Xuehui Zhao,Like Yang,Yushan Li,Ming Liu,Linli Tian,Yanan Sun,Qiuying Li

DOI: https://doi.org/10.3389/fonc.2024.1476128

2024-09-30

Abstract:[This corrects the article DOI: 10.3389/fonc.2019.01575.].

Corrigendum to “miR-183-5p Is a Potential Molecular Marker of Systemic Lupus Erythematosus”

Corrigendum: Alternative Splicing: a New Cause and Potential Therapeutic Target in Autoimmune Disease.

Corrigendum: MicroRNAs: Potential mediators between particulate matter 2.5 and Th17/Treg immune disorder in primary membranous nephropathy

Corrigendum to “Lipopolysaccharide-Induced Podocyte Injury is Regulated by Calcineurin/nfat and TLR4/MyD88/NF-κB Signaling Pathways Through Angiopoietin-like Protein 4” [genes &amp; Diseases 9(2022) 443–455]

Corrigendum: MicroRNAs as Regulators of Immune and Inflammatory Responses: Potential Therapeutic Targets in Diabetic Nephropathy

Erratum: [Corrigendum] miR‑216a‑5p acts as an oncogene in renal cell carcinoma.

Corrigendum: The Regulation Mechanisms and Clinical Application of MicroRNAs in Myocardial Infarction: A Review of the Recent 5 Years

Corrigendum: A Novel Autoantibody Induced by Bacterial Biofilm Conserved Components Aggravates Lupus Nephritis

Corrigendum: The potential role of RNA N6-methyladenosine in primary Sjögren's syndrome

Erratum to: "Fer exacerbates renal fibrosis and can be targeted by miR-29c-3p"

Corrigendum: Identification and validation of immune-related methylation clusters for predicting immune activity and prognosis in breast cancer

Corrigendum to"Synergistically targeting synovium STING pathway for rheumatoid arthritis treatment" [Bioact Mater 24 (2022) 37-53]

Corrigendum to “Lipopolysaccharide-induced podocyte injury is regulated by calcineurin/NFAT and TLR4/MyD88/NF-κB signaling pathways through Angiopoietin-like protein 4” [Genes & Diseases 9(2022) 443-455]

Erratum to “miR-223 Inhibits the Polarization and Recruitment of Macrophages via NLRP3/IL-1β Pathway to Meliorate Neuropathic Pain”

[Corrigendum] miR‐216a‐5p acts as an oncogene in renal cell carcinoma

Corrigendum: Metabolomic analysis in spondyloarthritis: A systematic review

[Corrigendum] miR‐199b‐5p serves as a tumor suppressor in renal cell carcinoma

Corrigendum to "N6-methyladenosine modified LINC00901 promotes pancreatic cancer progression through IGF2BP2/MYC axis" [Genes & Diseases 10 (2023) 554-567]

Erratum to "Inhibition of miR-21 improves pulmonary vascular responses in bronchopulmonary dysplasia by targeting the DDAH1/ADMA/NO pathway"

Corrigendum: Single-cell RNA Sequencing of Peripheral Blood Mononuclear Cells from Acute Myocardial Infarction.

Corrigendum: A novel LncRNA, AC091729.7 promotes sinonasal squamous cell carcinomas proliferation and invasion through binding SRSF2

Corrigendum to “Lipopolysaccharide-Induced Podocyte Injury is Regulated by Calcineurin/nfat and TLR4/MyD88/NF-κB Signaling Pathways Through Angiopoietin-like Protein 4” [genes & Diseases 9(2022) 443–455]